Advertisement
Advertisement

ROIV

ROIV logo

Roivant Sciences Ltd. Common Shares

29.22
USD
Sponsored
-0.17
-0.58%
May 13, 16:00 UTC -4
Closed
exchange

Pre-Market

29.65

+0.43
+1.49%

Roivant Sciences Ltd. Common Shares Profile

About

Roivant Sciences is a biopharmaceutical company dedicated to improving the delivery of healthcare to patients. Roivant Sciences, formerly known as Montes Archimedes Acquisition Corp., is based in NEW YORK.

Info & Links

CEO

Matthew Gline

Headquarters

7th Floor 50 Broadway
LONDON, X0 SW1H 0DB, UNITED KINGDOM

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

https://roivant.com

Auditor

Ernst & Young LLP

Share holders

64

Employees

750

Roivant Sciences Ltd. Common Shares Statistics

Valuation Measures

Market Capitalization2

21.22B

Enterprise Value

19.75B

Enterprise Value/EBITDA(ttm)

-16.30

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

1.53K

Price to Book(mrq)

4.06

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

87.03%

Operating Margin(ttm)

-7076.27%

Profit Margin(ttm)

-8386.88%

Return on Equity(ttm)

-19.04%

Return on Invested Capital(ttm)

-20.31%

Return on Assets(ttm)

-18.15%

Income Statement

Revenue(ttm)

13.31M

Revenue Per Share(ttm)

0.02

Gross Profit(ttm)

12.14M

EBITDA(ttm)3

-1.21B

Net Income Available to Common(ttm)

-809.24M

Diluted EPS(ttm)

-1.17

Share Statistics

Beta (5Y Monthly)

1.20

52-Week Change

171.56%

S&P 500 52-Week Change

26.33%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

715.70M

Dividend Yield

0.00%

Float4

638.40M

% Held by Insiders

10.80%

% Held by Institutions

64.76%

Balance Sheet

Total Cash(mrq)

4.53B

Total Cash Per Share(mrq)

6.33

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

30.66%

Quick Ratio(mrq)

30.66%

Book Value Per Share(mrq)

7.01

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.84

Free Cash Flow(ytd)

-593.48M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement